|
|
Adverse Reactions of Tacrolimus and Priorities of Clinical Pharmaceutical Care |
YUAN Fang, WU Xiuzhi |
Department of Pharmacy, the Fifty-ninth Central Hospital of PLA, Kaiyuan, Yunnan 661600, China |
|
|
Abstract By summarizing the related studies on adverse reactions of tacrolimus, and analyzing the clinical and pharmacokinetic characteristics, targeted clinical pharmaceutical care measures were proposed in an attempt to optimize treatment regimens, minimizethe occurrence of adverse reactions of tacrolimus, promote the rational use of drugs, improve the prognosis of patients and prevent possible disputes between doctors and patients.
|
Received: 18 March 2016
Published: 05 January 2017
|
|
|
|
[1] |
徐芳,翟所迪,胡永芳,等.他克莫司发生药物相互作用的分子机制[J].中国药学杂志,2007,42(13):965.
|
[2] |
高其水,韩淑华,苏乐群,等.他克莫司应用中的药学服务[J].药学研究,2015,34(2):109.
|
[3] |
史天陆,孙言才,沈爱宗,等.他克莫司临床不良反应与防治[J].中国医院用药评价与分析,2009,9(1):67.
|
[4] |
邬蓉,陈万生,金晓玲,等.原位肝移植术后患者早期神经毒性反应与他克莫司血药浓度的关系[J].第二军医大学学报,2007,28(12):1381.
|
[5] |
WILLIAM F F.FK506 nephrotaxicity[J].Renal Failun,1999:21:319.
|
[6] |
陈家存,马平.FK506肾毒性的预防[J].徐州医学院学报,1999,19(4):325.
|
[7] |
王波,田慧,巴建明,等.他克莫司引起继发性糖尿病的临床转归和药学监护[J].中国药物应用与监测,2011,8(1):26.
|
[8] |
张弋,付鹏,郑虹等.他克莫司在151例肝移植受者的常规监测的群体药动学研究[J].中国药学杂志,2008,43(24):1897.
|
[9] |
史天陆,孙言才,沈爱宗,等.他克莫司临床不良反应与防治[J].中国医院用药评价与分析,2009,9(1):67.
|
[10] |
滕雅芹,牛玉坚,徐春,等.他克莫司对大鼠血糖的影响及其作用机制[J].中国实验动物学报,2012,20(2):74.
|
[11] |
GEMA F F,EMILIO R,ROSALIA V.Traditional cardiovascular risk factors as clinical markers after kidney transplantation[J].Transportation Reviews,2006,(02):88.
|
[12] |
席兰艳,袁洪,成柯,等.移植后高血压与他克莫司剂量及血药浓度的关系[J].中国临床药理学与治疗学,2012,17(1):78.
|
[13] |
张弋,呼自顺,高仲阳.他克莫司的药物相互作用[J].中国医院药学杂志,2002,22 (2):106.
|
[14] |
王志宏,刘蕾.他克莫司的药物相互作用研究进展[J].临床合理用药,2011,4(1):117.
|
No related articles found! |
|
|
|
|